BC
Bruce & Co Portfolio holdings
AUM
$308M
This Quarter Return
-3.04%
1 Year Return
+16.62%
3 Year Return
+23.4%
5 Year Return
+75.93%
10 Year Return
+183.38%
AUM
$356M
AUM Growth
+$356M
(-2.8%)
Cap. Flow
-$501K
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
68.91%
Holding
38
New
–
Increased
2
Reduced
2
Closed
–
Top Buys
| 1 |
Caribou Biosciences
CRBU
|
$425K |
| 2 |
LAVA Therapeutics
LVTX
|
$203K |
Top Sells
| 1 |
Apple
AAPL
|
$970K |
| 2 |
AT&T
T
|
$160K |
Sector Composition
| 1 | Healthcare | 35.61% |
| 2 | Utilities | 29.35% |
| 3 | Industrials | 13.26% |
| 4 | Communication Services | 5.9% |
| 5 | Financials | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$210B
| $34.7M | 9.72% | 300,372 | – | – |
|
2
U-Haul Holding Co Series N
UHAL.B
$9.79B
| $32.5M | 9.1% | 640,530 | – | – |
|
3
AbbVie
ABBV
$372B
| $25.8M | 7.25% | 191,743 | – | – |
|
4
NextEra Energy, Inc.
NEE
$148B
| $25.6M | 7.18% | 345,114 | – | – |
|
5
CMS Energy
CMS
$21.4B
| $24.5M | 6.87% | 416,755 | – | – |
|
6
Duke Energy
DUK
$95.3B
| $23.4M | 6.55% | 260,319 | – | – |
|
7
Xcel Energy
XEL
$42.8B
| $23.1M | 6.48% | 371,754 | – | – |
|
8
Pfizer
PFE
$141B
| $19.8M | 5.54% | 538,626 | – | – |
|
9
Allstate
ALL
$53.6B
| $18.2M | 5.1% | 166,844 | – | – |
|
10
Abbott
ABT
$231B
| $18.2M | 5.1% | 166,843 | – | – |
|
|
11
AT&T
T
$209B
| $17.9M | 5.01% | 1,120,254 -10,000 | -0.9% | -$160K |
|
|
12
Apple
AAPL
$3.45T
| $11.4M | 3.2% | 58,801 -5,000 | -8% | -$970K |
|
13
Insteel Industries
IIIN
$745M
| $10.7M | 3% | 343,423 | – | – |
|
14
Avista
AVA
$2.96B
| $8.05M | 2.26% | 205,000 | – | – |
|
15
Bausch Health
BHC
$2.74B
| $7.42M | 2.08% | 925,780 | – | – |
|
|
EDAP
16
EDAP TMS
EDAP
$84.5M
| $5.24M | 1.47% | 565,652 | – | – |
|
|
17
U-Haul Holding Co
UHAL
$10.8B
| $4.14M | 1.16% | 74,764 | – | – |
|
|
PRTK
18
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.44M | 0.96% | 1,556,247 | – | – |
|
19
Kodiak Sciences
KOD
$478M
| $3.26M | 0.91% | 473,000 | – | – |
|
20
SiriusXM
SIRI
$7.96B
| $2.99M | 0.84% | 657,843 | – | – |
|
21
Newmont
NEM
$81.7B
| $2.8M | 0.79% | 65,600 | – | – |
|
22
Supernus Pharmaceuticals
SUPN
$2.53B
| $2.47M | 0.69% | 82,105 | – | – |
|
|
23
LAVA Therapeutics
LVTX
$41.3M
| $1.57M | 0.44% | 771,874 +100,000 | +15% | +$203K |
|
24
Ashland
ASH
$2.57B
| $1.3M | 0.37% | 15,000 | – | – |
|
25
Fate Therapeutics
FATE
$120M
| $956K | 0.27% | 200,000 | – | – |
|